Aldevron expands antibody development facility in Freiburg, Germany

pharmanewsdaily- March 4, 2019 0

Aldevron, a US-based contract development and manufacturing organisation (CDMO), has unveiled plans to expand its antibody development facility located in Freiburg, Germany. The Freiburg site, ... Read More